SUSQUEHANNA INTERNATIONAL GROUP, LLP - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$331,559
+50.6%
142,300
+53.8%
0.00%
Q2 2023$220,150
+207.2%
92,500
+137.5%
0.00%
Q1 2023$71,662
+4.8%
38,947
+8.2%
0.00%
Q4 2022$68,406
+163.1%
36,003
+196.6%
0.00%
Q3 2022$26,000
-66.2%
12,140
-55.2%
0.00%
Q2 2022$77,000
-58.2%
27,117
-38.6%
0.00%
Q1 2022$184,000
-79.6%
44,200
-74.6%
0.00%
Q4 2021$900,000
+26.9%
173,740
+60.4%
0.00%
Q3 2021$709,000108,3000.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,530,657$23,126,0001.85%
TFG Asset Management GP Ltd 2,500,000$16,375,0001.00%
Nantahala Capital Management 2,936,791$19,236,0000.61%
MYDA Advisors LLC 171,953$1,126,0000.32%
SABBY MANAGEMENT, LLC 300,000$1,965,0000.27%
Regency Capital Management Inc.\DE 57,000$373,0000.26%
Ikarian Capital, LLC 544,819$3,568,0000.25%
Eversept Partners, LP 398,074$2,607,3850.18%
Henry James International Management Inc. 54,047$354,0000.11%
Alphabet Inc. 698,262$4,574,0000.11%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders